IL15 and ovarian cancer: These antibody fragments could simultaneously bind with both NK cells and ovarian cancer cells, and the IL-15 portion was applied to specifically mediate IL-15 signaling on NK cells when inducing ADCC effects for triggering robust NK expansion.